REDUCED试验:一项减少难产剖宫产的整群随机试验
该整群随机对照试验在加拿大26家医院评估推广新产程停滞诊断指南能否降低剖宫产率。干预组45193例与对照组43725例分娩分析显示,剖宫产率无显著下降(基线校正OR 0.94,95%CI 0.85-1.05,P=.259),自然阴道分娩率略升(OR 1.10,95%CI 1.01-1.18,P=.024),母婴不良结局无差异。
要点
- 推广新产程停滞诊断指南未降低初产妇剖宫产率(OR 0.94,95%CI 0.85-1.05)。
- 干预组自然阴道分娩率略升(OR 1.10,95%CI 1.01-1.18,P=.024)。
- 未观察到母婴不良结局差异,干预似乎安全。
核心结论
- 应用近期产程停滞诊断指南未降低初产妇剖宫产率,干预组自然阴道分娩(次要结局)增加,干预似乎安全。
研究设计与样本
- 在加拿大26家医院(13家对照、13家干预)开展的知识转化项目整群随机对照试验,纳入艾伯塔省所有年分娩至少70例初产妇且实施剖宫产的产时保健机构。
- 基线期始于2015年1月1日,干预于2017年1月在某干预点启动,随访期自2017年2月至2020年2月。
- 主要结局为足月初产妇头位临产剖宫产率,次要结局包括自然阴道分娩及母婴安全,数据主要来自艾伯塔围产期健康项目数据库。
主要发现
- 分析基于干预组45193例与对照组43725例分娩。
- 剖宫产率未见干预相关下降(基线校正OR 0.94,95%CI 0.85-1.05,P=.259)。
- 自然阴道分娩率略升(基线校正OR 1.10,95%CI 1.01-1.18,P=.024)。
- 未观察到母婴不良结局差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To reduce cesarean delivery rates in nulliparous women, guidelines for diagnosing nonprogressive labor have been developed by the National Institute of Child Health and Human Development, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine. These are mainly based on data from the Consortium for Safe Labor study. The guidelines have not been tested in a clinical trial, so the efficacy and safety of this new approach is uncertain. OBJECTIVE: This study aimed to assess whether adoption of new guidelines for diagnosing nonprogressing labor would reduce cesarean delivery rates. STUDY DESIGN: We conducted a cluster randomized controlled trial of a knowledge translation program of the guidelines in 26 Canadian hospitals (13 control sites and 13 intervention sites). The sites included all intrapartum care sites in Alberta that perform cesarean delivery and deliver at least 70 nulliparous women annually. The baseline period started on January 1, 2015. The intervention was initiated at the first intervention site in January 2017. The follow-up period began at the first intervention site in February 2017 and lasted till February 2020. The primary outcome was the rate of cesarean delivery in nulliparous women with vertex presentation in labor at term. The secondary outcomes included spontaneous vaginal birth and maternal and neonatal safety. The main data source for the primary and secondary outcomes was the Alberta Perinatal Health Program database. The cesarean delivery rates were assessed using repeated measures mixed effects logistic regression applied to individual births. RESULTS: The analysis was based on 45,193 deliveries at intervention sites and 43,725 deliveries at control sites. There was no evidence of a decrease in the rate of cesarean delivery in association with the intervention (baseline-adjusted odds ratio, 0.94; 95% confidence interval [0.85-1.05]; P=.259). The rate of spontaneous vaginal delivery increased slightly (baseline-adjusted odds ratio, 1.10; 95% confidence interval, [1.01-1.18]; P=.024). We did not observe any differences in adverse maternal or neonatal outcomes. CONCLUSION: Cesarean delivery rates in nulliparous women were not reduced by the application of recent guidelines for the diagnosis of nonprogressive labor. Spontaneous vaginal delivery-a secondary outcome-was increased in the intervention group. The intervention appears to be safe.
引用
- Wood S, Skiffington J, Brant R, et al. The REDUCED trial: a cluster randomized trial for REDucing the utilization of CEsarean delivery for dystocia. Am J Obstet Gynecol. 2023. PMID: 37164490. doi:10.1016/j.ajog.2022.10.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。